Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01 HL091528)
National Institutes of Health (U54 HL119145)
American Heart Association (D007382)
Received: 14 May 2020
Accepted: 25 September 2020
First Online: 12 October 2020
: JL is the scientific co-founder of Scipher Medicine, Inc., a company that uses molecular network medicine strategies to identify disease biomarkers and therapeutic targets.